High-dose tirofiban pretreatment reduces the need for bail-out study medication in patients with ST-segment elevation myocardial infarction: Results of a subgroup analysis of the On-TIME 2 trial

Heart

Volumn 97, Issue 2, 2011, Pages 106-111

  Hermanides, R S ^a   Heestermans, A A C M ^b   Ten Berg, J M ^c   Gosselink, A T M ^a   Ottervanger, J P ^a   Van Houwelingen, K G ^d   Kolkman, J J E ^e   Stella, P R ^f   Dill, T ^g   Hamm, C ^g   Van 't Hof, Arnoud W J ^a  

^a ISALA HOSPITAL   (Netherlands)

^b Location Alkmaar   (Netherlands)

^c ST ANTONIUS HOSPITAL   (Netherlands)

^d MEDISCH SPECTRUM TWENTE   (Netherlands)

^e Diagram BV   (Netherlands)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^g KERCKHOFF HEART CENTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; PLACEBO; TIROFIBAN;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CONTROLLED STUDY; DRUG MEGADOSE; ELECTROCARDIOGRAPHY; FEMALE; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; ST SEGMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TREATMENT OUTCOME;

ANGIOPLASTY, BALLOON, CORONARY; DOUBLE-BLIND METHOD; EMERGENCY MEDICAL SERVICES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PREOPERATIVE CARE; TREATMENT OUTCOME; TYROSINE;

EID: 78651248926     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2010.194951     Document Type: Article

References (24)

1. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003;361:13-20. (Pubitemid 36050955)
2. Schömig A, Neumann FJ, Kastrati A, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 1996;334:1084-9.
3. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001;104:365-72.
4. Steinhubl SR, Berger PB, Mann JT III, et al; CREDO investigators. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002;288:2411-20.
5. Svilaas T, Vlaar PJ, van der Horst IC, et al. Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med 2008;358:557-67.
6. Montalescot G, Wiviot SD, Braunwald E, et al. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial. Lancet 2009;373:723-31.
7. Stone GW, Witzenbichler B, Guagliumi G, et al; HORIZONS-AMI trial investigators. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med 2008;358:2218-30.
8. Montalescot G, Antoniucci D, Kastrati A, et al. Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analysis on individual patient's data with long-term follow-up. Eur Heart J 2007;28:443-9. (Pubitemid 47343560)
9. Matetzky S, Shenkman B, Guetta V, et al. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation 2004;109:3171-5.
10. De Luca G, van 't Hof AWJ, Ottervanger JP, et al. Unsuccessful reperfusion in patients with ST-segment elevation myocardial infarction treated by primary angioplasty. Am Heart J 2005;150:557-62.
11. De Luca G, Ernst N, van 't Hof AWJ, et al. Predictors and clinical implications of early reinfarction after primary angioplasty for ST-segment elevation myocardial infarction. Am Heart J 2006;151:1256-9.
12. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation 2004;110:588-636.
13. Antman EM, Hand M, Armstrong PW, et al. 2007 Focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the ACC/AHA Task Force on Practice Guidelines. J Am Coll Cardiol 2008;58:210-47.
14. De Luca G, Gibson CM, Bellandi F, et al. Early glycoprotein IIb/IIIa inhibitors in primary angioplasty (EGYPT) cooperation: an individual patient data meta-analysis. Heart 2008;94:1548-58.
15. van 't Hof AWJ, ten Berg JM, Heestermans AA, et al. Ongoing Tirofiban In Myocardial infarction Evaluation (On-TIME) 2 study group. Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial. Lancet 2008;372:537-46.
16. van 't Hof AWJ, Hamm C, Rasoul S, et al; on behalf of the On-TIME 2 investigators. Ongoing tirofiban in myocardial infarction evaluation (On-TIME) 2 trial: rationale and study design. EuroInterv 2007;3:371-80.
17. De Luca G, Maas AC, Suryapranata H, et al. Prognostic significance of residual cumulative ST-segment deviation after mechanical reperfusion in patients with ST-segment elevation myocardial infarction. Am Heart J 2005;150:1248-54.
18. van 't Hof AWJ, Liem AL, de Boer MJ, et al; on behalf of the Zwolle Myocardial Infarction Study Group. Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Lancet 1997;350:615-19.
19. Sejersten M, Loumann Nielsen S, Engstrom T, et al; Feasibility and safety of prehospital administration of bivalirudin in patients with ST-elevation myocardial infarction. Am J Cardiol 2009;103:1635-40.
20. Budaj A, Brieger D, Steg PG, et al; GRACE investigators. Global patterns of use of antithrombotic and antiplatelet therapies in patients with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 2003;146:999-1006.
21. Mandelzweig L, Battler A, Boyko V, et al; Euro Heart Survey Investigators. The second Euro Heart Survey on acute coronary syndromes: characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004. Eur Heart J 2006;27:2285-93.
22. Ashby DT, Aymong EA, Tcheng JE, et al. Outcomes following bail-out abciximab administration during primary intervention in acute myocardial infarction (the CADILLAC Trial). Am J Cardiol 2003;92:1091-4.
23. Cantor WJ, Madan M, O'Shea JC, et al. Bailout use of platelet glycoprotein IIb/IIIa inhibition during coronary stent implantation: observations from the ESPRIT trial. J Invasive Cardiol 2005;17:360-4.
24. Ellis SG, Tendera M, de Belder MA, et al. Facilitated PCI in patients with ST-elevation myocardial infarction. N Engl J Med 2008;358:2205-17.